Product Information
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Hospira Inc., priced at $0.7371 per ML under NDC 00409330803. Its NADAC has been published 579 times since Nov 28, 2013.
FDA first approved this application on Aug 30, 1994. Its Orange Book therapeutic-equivalence code is AN.
The Low Outlier badge above means this manufacturer's average price in the ACETYLCYSTEINE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
Hospira Inc.NDC
00409330803
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL; RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA074037FDA Approved
8/30/1994
TE Code
AN
On Market Since
6/1/2005
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 579 times since Nov 28, 2013, and over the history we have for it it has risen 133.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7371 per ML |
|---|---|
| All-time high | $0.7751 (Aug 14, 2024) |
| All-time low | $0.2303 (Feb 19, 2014) |
| 52-week high | $0.7447 |
| 52-week low | $0.6744 |
| Median price | $0.3337 |
| Average price | $0.4068 |
| Largest weekly change | +108.4% (Apr 17, 2024) |
| Weeks tracked | 579 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETYLCYSTEINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antidote class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Hospira Inc., is $0.7371 per ML (NDC 00409330803), effective Sep 30, 2026.
How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 133.8%. It has been tracked across 579 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Since Nov 28, 2013, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $0.2303 (Feb 19, 2014) to a high of $0.7751 (Aug 14, 2024), with a median of $0.3337 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) in a comparable dosage form, but none are currently priced below it.
Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 00409330803) is labeled by Hospira Inc., and CMS classifies it as a generic product.